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Abstract  
Background: One of the frequent health problems that regularly occurs in Indonesia, as a tropical 
country is an acute respiratory tract infection, including influenza. Since immunological benefit of 
vitamin D already proven, hypothetically, vitamin D can be used as protective agent to prevent 
influenza or other respiratory tract infections. 
Objectives: This evidence-based case report was focused on the evaluation of protective ability of 
vitamin D supplementation to prevent influenza or other acute respiratory tract infections. 
Methods: Literature searching was conducted on PubMed data base and Cochrane Library using 
the related keyword combinations. 
Results: Two randomized-clinical trials (RCTs) and a meta-analysis study were fulfilled the eligibility 
criteria. Vitamin D supplementation did not reduce the incidence of influenza but reduce the 
incidence of non-influenza infection. High-dose vitamin D supplementation had no effect on the 
reduction of acute respiratory tract infection incidence. The meta-analysis concluded that vitamin 
D supplementation reduced the risk for acute respiratory tract infection and the stronger effects 
occurred on low-levels of vitamin D serum. 
Conclusions: Vitamin D supplementation may prevent acute respiratory tract infections, especially 
in subjects with low-levels of vitamin D serum. 
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Introduction 
 
Acute respiratory tract infection was occurred on 
46% of population/years. Influenza were prevalent 
in a third of them. This health problem can affect 
people in all age-groups.1 As a tropical country, 
Indonesia has a greater risk for infectious disease, 
including acute respiratory tract infection. Fourteen 
percent of all severe acute respiratory tract infection  
 
is caused by influenza. The incidence is highest in 
childhood population.2 
Various micronutrients are proposed to be 
protective role to prevent influenza or other acute 
respiratory tract infection, including vitamin D. 
Vitamin D has various beneficial effect on immune 
responses. Several immune cells have receptor, 
hence be able to respond vitamin D. Vitamin D acts 
in autocrine or paracrine processes in B and T cells. 
It also enhanced the activities of macrophage and 
dendritic cells. Hypothetically, vitamin D 
supplementation can be used to prevent influenza or 
other acute respiratory tract infections.3,4 
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Clinical Illustration 
 
A 30- years old woman came with her son age 5-
years old as patient of clinical nutrition outpatient 
department in General Hospital. She tells her 
physicians that some of her son’s close friends in 
school had suffered from cough, rhinorrhea, and 
fever since a week ago. He routinely contacts with 
them during the school time. The mother worried 
that her son would be infected by his friends. She 
has vitamin D tablets in her house, so she was 
wondering could vitamin D supplementation 
prevent the disease ? 
 
Clinical questions 
 
Could vitamin D supplementation prevent 
influenza or other acute respiratory tract infections 
among children ? 
P : Children 
I : Vitamin D supplementation  
C: Placebo 
O: Prevent influenza or acute respiratory tract 
infection incidence 
 
Methods 
 
Article searching was conducted on PubMed 
database and the Cochrane Library on April 7, 2020. 
The key words combination on Table 1 were used 
within the searching process. English systematic 
review, meta-analysis, clinical trial or observational 
study in the last five years: 1 January 2014 ─ 31 
December 2019 publication were included. The 
study with other specific medical conditions (such 
as pregnant, cancer, bowel disease) were not 
included. An animal study and non-relevance article 
were also excluded.  Critical appraisal was 
conducted using critical appraisal tools for clinical 
trials and systematic review that published by The 
Center of Evidence-Based Medicine (CEBM) 
 
Results 
 
According to literature searching, with mentioned 
strategy, we obtained the literatures as presented 
number in Table 1 based on each key words 
combination. After duplicates removed, a total of 13 
articles were recorded. Four of them were excluded 
due to other specific condition including pregnancy 
(2 studies), asthma (1 study), and bowel disease (1 
study). The other six studies were excluded since not 
relevant topics. Finally, we obtained two 
randomized clinical trials and one-meta analysis.   
From two tables above we can see that vitamin D 
can protect against respiratory non influenza 
infection better than respiratory influenza infection. 
We needed 93 patients treated with vitamin D to 
prevent 1 patient infected with influenza contrasted 
with non influenza patients which only need 17 
patients treated to get the same results.  
 
Discussion 
 
Vitamin D expands the number of antimicrobial 
peptide cathelicidine in respiratory epithelium, 
which has been shown to reduce the severity of the 
disease and the replication of influenza virus in 
vitro.8 However we found a different result, vitamin 
D can protect someone from non-influenza 
respiratory infection rather than influenza itself, this 
findings need further research. A combination of the 
aims of these clinical trials could answer two 
dissected-clinical questions. After the necessity of 
vitamin D supplementation to prevent influenza or 
acute respiratory tract infection, we also could know 
which dose to be used for it. The two included 
clinical trials showed an almost concordant 
conclusion. Loeb et al5 reported that vitamin D 
supplementation did not reduce the incidence of 
influenza, but significantly reduced non-influenza 
viral infection. On the other hand, Aglipay et al6 
concluded the high-dose vitamin D supplementation 
did not reduce the incidence of viral respiratory tract 
infection, not specifically caused by influenza. The 
later also showed that compared to standard-dose 
vitamin D supplementation, the high-dose one had 
no difference in the median time to the first 
laboratory-confirmed infection and the number of 
laboratory-confirmed infections.  
As a strength of these two clinical trials, the 
outcomes were confirmed validly and accurately. 
The cause of infections was diagnosed using 
polymerases chain reaction (RT-PCR). Both clinical 
trials also described the distribution of infection 
causes. The two clinical trials had a similar 
limitation. Loeb et al5 had subjects with high-
baseline vitamin D levels among the two groups.   
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Meanwhile, Aglipay et al6 started the study early 
of the winter. Probably, it implicates the lack of 
effect of high-dose vitamin D supplementation due 
to high-baseline vitamin D serum level at the end of 
the summer was relatively high. Another limitation, 
due to restricted by ethical consideration, the clinical 
trial conducted by Aglipay did not compare the 
intervention group to placebo.  
The meta-analysis study confirmed the effect of 
vitamin D supplementation to reduce the incidence 
of acute respiratory tract infection. Vitamin D 
supplementation is a protective factor for all-cause 
of acute respiratory tract infection based on the 
adjusted odds ratio of 0.88. The meta-analysis also 
concluded that the protective effects of vitamin D 
supplementation were stronger in patients with low 
baseline vitamin D serum levels (< 25 nmol/L).7  
The clinical trials and meta-analysis also had 
two similar limitations. First, they did not analyze 
the potential confounders such as baseline 
nutritional status and record of dietary patterns. 
Some studies revealed underweight, overweight, 
and obesity as independent risk factors for 
influenza.9,10 Second, three included studies also did 
not analyzed the level of patient adherence on each 
study.  
 
Conclusion 
 
According to two clinical trials and one meta-
analysis, vitamin D supplementation neither reduce 
nor prevent influenza. However, high-dose of 
vitamin D supplementation may protect non-
influenza respiratory tract infection in patients with 
low-vitamin D serum levels. 
 
 
 
 
 
  World.Nutr.Journal | 4 
Table 1. Keyword and the numbers of included-articles 
Database Terminology Number of article(s) Hits Included 
Pubmed “vitamin D supplementation” AND “influenza” AND 
“prevention” 
6 2 
Pubmed “vitamin D supplementation” AND “influenza-like illness” 
AND “prevention” 
0 0 
Pubmed “vitamin D supplementation” AND “acute respiratory tract 
infection” AND “prevention” 
1 1 
Cochrane “vitamin D supplementation” AND “influenza” AND 
“prevention” 
13 2 
Cochrane  “vitamin D supplementation” AND “influenza-like illness” 
AND “prevention” 
0 0 
Cochrane “vitamin D supplementation” AND “acute respiratory tract 
infection” AND “prevention” 
0 0 
 
 
Table 2. Characteristics of each study 
 Loeb et al.5 Aglipay et al.6 Martineau et al.7 
Study Design (Levels 
of evidence) 
RCT (1B) RCT (1B) SR/MA (1A) 
Objective of the study To investigate the ability 
vitamin D supplementation to 
reduce influenza and other 
upper viral respiratory tract 
infections. 
To investigate whether high-
dose vs standard-dose 
vitamin D supplementation 
could prevent the wintertime 
upper respiratory tract 
infections in young children. 
To assess the overall effect of 
vitamin D supplementation on 
risk of acute respiratory tract 
infection. 
Patients (subjects) Children and adolescents aged 
3-17 years in Thanh Liem 
District of Vietnam. 
Young children aged 1-5 
years in Toronto, Canada. 
Broad range of age in total 
analysis.  
Intervention and 
Comparison 
Vitamin D (14.000 IU/week) 
versus placebo during 8 
months. 
High dose (2000 IU) versus 
standard dose  (400 IU) 
supplementation of vitamin D 
during 4-8 months 
Vitamin D supplementation 
(400 IU-30.000 IU) versus 
placebo. 
Number of Subjects 
(or study for meta-
analysis) 
650 vs. 650 subjects 349 vs. 354 subjects 25 RCT studies with 11.321 
total of subjects. 
Outcomes • The incidence of influenza 
between supplemented 
subjects was not different 
to placebo (7.7% vs 6.6%, 
Hazard ratio. [HR]: 1.18, 
95% CI: 0.79-1.78). 
• Vitamin D supplemented 
subjects had a lower 
incidence of non-influenza 
respiratory tract infection 
(22.5% vs 28.5%, HR 
0.76, 95% CI: 0.61-0.94)  
• There was no difference 
in the number of 
laboratory-confirmed 
infections among the 
groups. (RR, 0.97; 95% 
CI, 0.80-1.16). 
• There was no difference 
in the median time to the 
first laboratory-
confirmed infection: 3.95 
vs 3.29 months. 
• Vitamin D did not reduce 
the occurrence of non-
influenza respiratory 
tract infection (RR: 1.01; 
95% CI 0.83 to 1.23). 
• Vitamin D 
supplementation can 
reduce the risk of acute 
respiratory tract infection. 
(adjusted odds ratio: 0.88, 
95% CI 0.81-0.96). 
• Protective effects of 
vitamin D 
supplementation were 
stronger in patient with 
low baseline vitamin D 
serum level (< 25 nmol/L). 
 
 •  •  •  
 •  •  •  
 •  •  •  
 •  •  •  
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Table 2. Characteristics of each study (continued) 
 Loeb et al.5 Aglipay et al.6 Martineau et al.7 
Limitation At the baseline, vitamin D 
serum level of the subjects 
were not significantly different 
but they had high level vitamin 
D serum level. It makes the 
different of occurrence were 
not significantly different. 
The study conducted at the 
early winter. The basal 
vitamin D serum was high 
due to peak level of vitamin 
D serum was occurred in the 
end of summer. 
The dose-related effect were 
not accounted.  
The outcomes measurement in 
each study quietly different.  
Conclusion The incidence of influenza 
were not reduced by vitamin D 
supplementation. However, 
vitamin D reduced moderately 
non-influenza viral infection. 
Compared to standard dose, 
high-dose of vitamin D 
supplementation did reduced 
viral respiratory tract 
infection. 
Vitamin D supplementation 
can prevent the overall acute 
respiratory tract infection. 
 
 
Table 3. Validity Assessment for RCTS by Loeb et al and Aglipay et al 
Are the results of this single preventive therapeutic trial valid? 
Question Loeb et al Aglipay et al 
Was the assignment of patient to 
treatment randomised? And was the 
randomisation list concealed? 
Yes, patients were randomly assigned 
to either the experimental or placebo 
control group.  
Yes, the list was concealed, they use 
external research organization to 
ensure randomization and concealment 
purpose. 
 
Yes, patients were randomly assigned 
to either the high dose or standard dose 
group. 
Yes, the list was concealed.  
 
Were all patents who entered the 
trial accounted for at its conclusion? 
And were they analysed in the group 
to which they were randomised ? 
 
This study used intention to treat 
analysis. 
This study used intention to treat 
analysis. 
Were patients and clinicians kept 
blind to which treatment was being 
received ? 
 
Yes Yes 
Aside from the experimental 
treatment, were the groups treated 
equally? 
 
Yes Yes 
Were the groups similar at the start 
of the trial? 
Yes, we can check in the baseline 
characteristics table. 
Yes, we can check in the baseline 
characteristics table. 
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Validity 
 
Table 4. Validity assessment of meta-analysis by Martineau et al 
Are the results of this systematic review of therapy valid? 
Question Martineau et al 
Is it a systematic review of randomised trials of the 
treatment you’re interested in? 
Yes. 
Does it include a methods section that describes: finding 
and including all the relevant trials? 
Yes, it is explained in the Methods subsection “study 
identification and selection, and data collection process”. 
They included trials from any languages. They performed 
systematic search in major databases, but did not search 
unpublished material using handsearching method. 
 
Assessing their individual validity? Yes, quality of included studies were assessed using the 
Cochrane Collaboration risk of bias tool and five GRADE 
considerations (study limitations, consistency of effect, 
imprecision, indirectness, and publication bias). 
 
Were the results consistent from study to study? Yes, vitamin D supplementation can reduce the risk of acute 
respiratory tract infection. (adjusted odds ratio: 0.88, 95% CI 
0.81-0.96). 
 
 
Importance 
 
Table 4. Comparison of vitamin D and placebo on influenza infection  
  Intervention 
Influenza infection Vit D Placebo 
Yes 50 43 
No 600 607 
Absolute Risk Reduction (ARR) = 1% 
Number Needed to Treat (NNT) = 93 
 
Table 5. Comparison of Vitamin D and Placebo on Influenza Infection 
  Intervention 
Non Influenza infection Vit D Placebo 
Yes 146 185 
No 504 465 
ARR = 6% 
NNT = 17 
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Applicability 
 
Table 6. Critical appraisal on the applicability 
 Loeb et al.5 Aglipay et al.6 Martineau et al.7 
Resemblance of the 
study subjects with the 
case 
Children and adolescents aged 
3-17 years in Thanh Liem 
District of Vietnam. 
Resemblance is strong, since 
the case is Indonesian kid age 5  
Young children aged 1-5 
years old in Toronto, Canada. 
Moderate resemblance 
because different race 
Low resemblance because, this 
is a systematic review which 
include age 6 months until 80 
years old patients.  
Agreement to the 
value and preference 
in the community 
Very likely to agree since vitamin D is well known among Indonesian population. 
Feasibility of the 
therapy 
in the setting of daily 
clinical practice 
Very feasible, vitamin D is easily found everywhere in the local drug store. 
 
Figure 1. The PRISMA flowchart for the selection articles 
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